We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03773302
Brief Title: Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations
First Submitted : December 10, 2018
First Submitted that Met QC Criteria : December 10, 2018
First Posted : December 12, 2018
Last Update Submitted that Met QC Criteria : March 29, 2023
Last Update Posted : April 3, 2023